← Leaderboards
Samuel M Behar
Brigham And Women'S Hospital
$34,926,005
Attributed
$37,696,648
Total exposure
25
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,696,648 · 25
By mechanism
R01$27,413,738 · 11
P01$5,291,793 · 3
R21$2,745,486 · 6
R56$1,602,001 · 2
P60$303,601 · 1
R03$211,509 · 1
Top collaborators
- Sarah M Fortune5 shared
- Sylvie Le Gall4 shared
- Heinz Gernot Remold2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Patrick Joseph Brennan$2,752,380
- Jenny E Gumperz$7,778,810
- Jonathan Livny$772,877
- Manuela Cernadas$1,870,474
- Francis W. Luscinskas$14,265,022
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisMycobacterium TuberculosisImmunityCellsInfectionT-LymphocyteAffectMediatingVaccinesMacrophageImmune ResponsePreventResponsePulmonary TuberculosisLungIn VivoGrowthPathogenGlobal HealthTuberculosis ImmunityImmune SystemSignal TransductionCytokinePathway Interactions
Grant awards (86)
PROTECTIVE CD8 T CELL RESPONSES to TUBERCULOSIS$832,076
R01 · FY2025 · AI · contact PI
Hypoxia, tuberculosis, and T cell dysfunction$795,775
R01 · FY2025 · AI · contact PI
Project 3 Determinants of Vaccine Efficacy$468,043
P01 · FY2025 · AI · contact PI
The impact of IL-4 and IL-4-producing cells on protective immunity to tuberculosis$213,412
R21 · FY2025 · AI · contact PI
Hypoxia, tuberculosis, and T cell dysfunction$805,368
R01 · FY2024 · AI · contact PI
Project 3 Determinants of Vaccine Efficacy$594,375
P01 · FY2024 · AI · contact PI
The impact of IL-4 and IL-4-producing cells on protective immunity to tuberculosis$251,250
R21 · FY2024 · AI · contact PI
The role of CD38 in immunity to tuberculosis$209,375
R21 · FY2024 · AI · contact PI
Hypoxia, tuberculosis, and T cell dysfunction$729,692
R01 · FY2023 · AI · contact PI
The role of CD38 in immunity to tuberculosis$251,250
R21 · FY2023 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis$704,580
R01 · FY2022 · AI · contact PI
Granulysin and the antimicrobial activity of CD8T cells - development of a better model$251,250
R21 · FY2022 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis$704,580
R01 · FY2021 · AI · contact PI
Overcoming Genetic Variation in Vaccination$425,214
P01 · FY2021 · AI · contact PI
Granulysin and the antimicrobial activity of CD8T cells - development of a better model$209,375
R21 · FY2021 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis$704,580
R01 · FY2020 · AI · contact PI
Tuberculosis and T cell Recognition$687,018
R01 · FY2020 · AI · contact PI
Overcoming Genetic Variation in Vaccination$452,966
P01 · FY2020 · AI · contact PI
Focusing the vaccine-elicited T cell response on the recognition of Mtb-infected cells$209,375
R21 · FY2020 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis$704,580
R01 · FY2019 · AI · contact PI
Tuberculosis and T cell Recognition$690,876
R01 · FY2019 · AI · contact PI
Overcoming Genetic Variation in Vaccination$486,832
P01 · FY2019 · AI · contact PI
Focusing the vaccine-elicited T cell response on the recognition of Mtb-infected cells$251,250
R21 · FY2019 · AI · contact PI
The role of TIM-3 in regulating T cell function during tuberculosis$247,203
P01 · FY2019 · AI · contact PI
The role of alveolar macrophages during tuberculosis: detrimental or beneficial$209,375
R21 · FY2019 · AI · contact PI
Tuberculosis and T cell Recognition$694,621
R01 · FY2018 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis$687,808
R01 · FY2018 · AI · contact PI
Overcoming Genetic Variation in Vaccination$419,475
P01 · FY2018 · AI · contact PI
The role of TIM-3 in regulating T cell function during tuberculosis$392,221
P01 · FY2018 · AI · contact PI
The role of alveolar macrophages during tuberculosis: detrimental or beneficial$251,250
R21 · FY2018 · AI · contact PI
Tuberculosis and T cell Recognition$698,256
R01 · FY2017 · AI · contact PI
Overcoming Genetic Variation in Vaccination$493,872
P01 · FY2017 · AI · contact PI
The role of TIM-3 in regulating T cell function during tuberculosis$400,417
P01 · FY2017 · AI · contact PI
Tuberculosis and T cell Recognition$735,535
R01 · FY2016 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis (pending title)$647,771
R01 · FY2016 · AI · contact PI
Apoptosis and efferocytosis: regulators of immunity to tuberculosis$496,165
R01 · FY2016 · AI · contact PI
The role of TIM-3 in regulating T cell function during tuberculosis$428,728
P01 · FY2016 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis (pending title)$647,771
R01 · FY2015 · AI · contact PI
Apoptosis and efferocytosis: regulators of immunity to tuberculosis$496,165
R01 · FY2015 · AI · contact PI
The role of TIM-3 in regulating T cell function during tuberculosis$482,447
P01 · FY2015 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis (pending title)$647,771
R01 · FY2014 · AI · contact PI
Tim3 and Mycobacterium tuberculosis$529,109
R01 · FY2014 · AI · contact PI
Apoptosis and efferocytosis: regulators of immunity to tuberculosis$495,425
R01 · FY2014 · AI · contact PI
Regulation of CD8+ T cell immunity to tuberculosis (pending title)$605,572
R01 · FY2013 · AI · contact PI
Tim3 and Mycobacterium tuberculosis$494,393
R01 · FY2013 · AI · contact PI
Apoptosis and efferocytosis: regulators of immunity to tuberculosis$338,198
R01 · FY2013 · AI · contact PI
The effect of type I IFN and IL-12 signaling on T cell immunity to tuberculosis$208,125
R21 · FY2013 · AI · contact PI
Apoptosis and efferocytosis: regulators of immunity to tuberculosis$98,855
R01 · FY2013 · AI · contact PI
Tim3 and Mycobacterium tuberculosis$514,621
R01 · FY2012 · AI · contact PI
Antigen-specific CD8+ T cells and protective immunity to tuberculosis$506,783
R56 · FY2012 · AI · contact PI
Apoptosis and efferocytosis: regulators of immunity to tuberculosis$489,499
R01 · FY2012 · AI · contact PI
The effect of type I IFN and IL-12 signaling on T cell immunity to tuberculosis$230,199
R21 · FY2012 · AI · contact PI
Tim3 and Mycobacterium tuberculosis$511,443
R01 · FY2011 · AI · contact PI
Escape of Mycobacterium tuberculosis from the macrophage is regulated by eicosano$533,580
R56 · FY2010 · AI
Cd1d regulation and its effect on NKT cell activation$521,447
R01 · FY2010 · HL · contact PI
Tim3 and Mycobacterium tuberculosis$517,805
R01 · FY2010 · AI · contact PI
Antigen-specific CD8+ T cells and protective immunity to tuberculosis$377,211
R01 · FY2010 · AI · contact PI
Escape of Mycobacterium tuberculosis from the macrophage is regulated by eicosano$561,638
R56 · FY2009 · AI
Cd1d regulation and its effect on NKT cell activation$506,260
R01 · FY2009 · HL · contact PI
Antigen-specific CD8+ T cells and protective immunity to tuberculosis$418,522
R01 · FY2009 · AI · contact PI
Cd1d regulation and its effect on NKT cell activation$491,515
R01 · FY2008 · HL · contact PI
Antigen-specific CD8+ T cells and protective immunity to tuberculosis$393,521
R01 · FY2008 · AI · contact PI
Treatment of tuberculosis with immunomodulators$370,635
R01 · FY2008 · HL · contact PI
Cd1d regulation and its effect on NKT cell activation$477,199
R01 · FY2007 · HL · contact PI
Antigen-specific CD8+ T cells and protective immunity to tuberculosis$388,400
R01 · FY2007 · AI · contact PI
Treatment of tuberculosis with immunomodulators$370,635
R01 · FY2007 · HL · contact PI
Cd1d regulation and its effect on NKT cell activation$477,138
R01 · FY2006 · HL · contact PI
Antigen-specific CD8+ T cells and protective immunity to tuberculosis$400,000
R01 · FY2006 · AI · contact PI
Treatment of tuberculosis with immunomodulators$381,704
R01 · FY2006 · HL · contact PI
Treatment of tuberculosis with immunomodulators$390,890
R01 · FY2005 · HL
Treatment of tuberculosis with immunomodulators$390,890
R01 · FY2004 · HL
ROLE OF THE ALPHAE INTEGRIN IN IMMUNITY TO TUBERCULOSIS$381,375
R01 · FY2004 · AI
IMMUNOLOGICAL BASIS OF SUSCEPTIBILITY TO TUBERCULOSIS$423,750
R01 · FY2003 · HL
ROLE OF THE ALPHAE INTEGRIN IN IMMUNITY TO TUBERCULOSIS$381,375
R01 · FY2003 · AI
TREATMENT OF TUBERCULOSIS WITH IMMUNOMODULATORS$70,503
R03 · FY2003 · AI
IMMUNOLOGICAL BASIS OF SUSCEPTIBILITY TO TUBERCULOSIS$423,750
R01 · FY2002 · HL
ROLE OF THE ALPHAE INTEGRIN IN IMMUNITY TO TUBERCULOSIS$343,238
R01 · FY2002 · AI
TREATMENT OF TUBERCULOSIS WITH IMMUNOMODULATORS$70,503
R03 · FY2002 · AI
IMMUNOLOGICAL BASIS OF SUSCEPTIBILITY TO TUBERCULOSIS$423,750
R01 · FY2001 · HL
ROLE OF THE ALPHAE INTEGRIN IN IMMUNITY TO TUBERCULOSIS$381,375
R01 · FY2001 · AI
TREATMENT OF TUBERCULOSIS WITH IMMUNOMODULATORS$70,503
R03 · FY2001 · AI
IMMUNOLOGICAL BASIS OF SUSCEPTIBILITY TO TUBERCULOSIS$381,375
R01 · FY2000 · HL
ROLE OF THE ALPHAE INTEGRIN IN IMMUNITY TO TUBERCULOSIS$211,875
R01 · FY2000 · AI
MONOCYTE DEPENDENT COSTIMULATION OF CD28 T CELLS$157,130
P60 · FY2000 · AR
MONOCYTE DEPENDENT COSTIMULATION OF CD28 T CELLS$146,471
P60 · FY2000 · AR
SECOND COSTIMULATORY PATHWAY PREVENTS T CELL ANERGY$128,520
K08 · FY2000 · AR